Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 10;37(1):60-68.
doi: 10.1080/19317611.2024.2420048. eCollection 2025.

Evaluation of the Efficacy and Safety of On-Demand Tadalafil Alone or Combined With Lidocaine Spray for Treating Patients With Comorbid Erectile Dysfunction and Premature Ejaculation: A Randomized Controlled Trial

Min Liu  1 , Zi Xiang Deng  2 , Xianxiang Zhu  2 , ShiAn Hu  3
Affiliations

Evaluation of the Efficacy and Safety of On-Demand Tadalafil Alone or Combined With Lidocaine Spray for Treating Patients With Comorbid Erectile Dysfunction and Premature Ejaculation: A Randomized Controlled Trial

Min Liu et al. Int J Sex Health. .

Abstract

Background: To evaluate the efficacy and safety of on-demand 20 mg tadalafil alone or combined with lidocaine spray for treating patients with comorbid erectile dysfunction (ED) and premature ejaculation (PE).

Methods: This randomized controlled trial included 98 patients with comorbid ED and PE, randomly assigned to the experimental group (n = 50, tadalafil alone) or the active control group (n = 48, tadalafil combined with lidocaine spray). Patients took tadalafil 30 min before sexual intercourse, while the combination therapy group also used lidocaine spray 5 min before intercourse. After 12 weeks of treatment, changes in the International Index of Erectile Function (IIEF-5), Chinese Index of Premature Ejaculation (CIPE-5), Intravaginal Ejaculatory Latency Time (IELT), and Sexual Satisfaction Score (SSS) were evaluated.

Results: Both groups showed significant improvement in IIEF-5 scores, but the difference between groups was not significant (F = 0.89, p = 0.45). The active control group showed significant improvement in CIPE-5 scores (p < 0.001), while the experimental group showed no significant change (p > 0.05). IELT in the active control group increased significantly from 25.7 s to 198.6 s (Z = 6.03, p < 0.001), while the experimental group showed no significant change (Z = 0.74, p = 0.46). SSS improved significantly in the active control group (p < 0.001) but not in the experimental group (p > 0.05). The incidence of adverse events was similar in both groups (14% vs 20.8%, p = 0.575).

Conclusion: Tadalafil combined with lidocaine spray is superior to tadalafil alone in improving symptoms, prolonging IELT, and enhancing sexual satisfaction in patients with comorbid ED and PE, with comparable safety. This combination therapy provides a new approach for improving treatment strategies for patients with comorbid ED and PE. Large-scale, multi-center randomized controlled trials are needed to further validate these findings.

Keywords: Erectile dysfunction; lidocaine spray; premature ejaculation; randomized controlled trial; tadalafil.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Clinical research flowchart.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Abu El-Hamd, M. (2021). Effectiveness and tolerability of lidocaine 5% spray in the treatment of lifelong premature ejaculation patients: A randomized single-blind placebo-controlled clinical trial. International Journal of Impotence Research, 33(1), 96–101. 10.1038/s41443-019-0225-9 - DOI - PubMed
    1. Abu El-Hamd, M., & Abdelhamed, A. (2018). Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil, and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial. Andrologia, 50(1), e12829. 10.1111/and.12829 - DOI - PubMed
    1. Althof, S. E., Rosen, R. C., Harty, B., Osterloh, I. H., Muirhead, G. J., & McMahon, C. (2020). Objective and subjective measures of premature ejaculation: How closely do they correspond and how well are the subjective measures recalled? The Journal of Sexual Medicine, 17(4), 634–644. 10.1016/j.jsxm.2020.01.002 - DOI - PubMed
    1. Assasa, M., Mohammed, E., Moustafa, O., et al. (2019). Histopathological study of the chronic toxic effects of dapoxetine administration on testes of male albino rats. The Egyptian Journal of Hospital Medicine, 76(3), 3651–3658. 10.12816/EJHM.2019.28521 - DOI
    1. Bai, Y., Pu, C., Han, P., Li, J., Yuan, H., Tang, Y., Wang, X., & Wei, Q. (2015). Selective serotonin reuptake inhibitors plus phosphodiesterase-5 inhibitors for premature ejaculation: A systematic review and meta-analysis. Urology, 86(4), 758–764. 10.1016/j.urology.2015.05.004 - DOI - PubMed

LinkOut - more resources